MSD AND THE WELLCOME TRUST INVEST IN TRANSFORMATIVE AFFORDABLE VACCINES by Morgane De Pol | Feb 10, 2020
BIOMÉRIEUX LEADS EUROPEAN EFFORT TO QUANTIFY DIAGNOSTICS’ VALUE TO COMBAT AMR by Morgane De Pol | Feb 10, 2020
AEQUOR’S NOVEL MOLECULES COUNTER BIOFILM ASSOCIATED WITH HOSPITAL-ACQUIRED INFECTIONS by Morgane De Pol | Feb 10, 2020
Peptilogics Receives Qualified Infectious Disease Product Designation from FDA for Lead Compound PLG0206 as a Treatment for Prosthetic Joint Infection by Morgane De Pol | Jun 7, 2018
